Inventor · disambiguated record
Joseph T. Bruder
Also filed as: BRUDER JOSEPH · BRUDER JOSEPH T
25 granted patents·22 pending applications·1,515 citations·filing 1995–2023
97Inventor score
Top patents by PatentIndex Score
47 records- 0198US5994106AStocks of recombinant, replication-deficient adenovirus free of replication-competent adenovirusGENVEC INC·Filed 1996·Granted Nov 30, 1999·405 cites·24 claims
- 0297US5851806AComplementary adenoviral systems and cell linesGENVEC INC·Filed 1995·Granted Dec 22, 1998·290 cites·63 claims
- 0396US7195896B2Complementary adenoviral vector systems and cell linesGENVEC INC·Filed 2001·Granted Mar 27, 2007·74 cites·40 claims
- 0495US6482616B1RCA-free adenoviral vector system and propagation methodGENVEC INC·Filed 1999·Granted Nov 19, 2002·97 cites·10 claims
- 0595US5770442AChimeric adenoviral fiber protein and methods of using sameCORNELL RES FOUNDATION INC·Filed 1995·Granted Jun 23, 1998·173 cites·89 claims
- 0694US5731190APenton base protein and methods of using sameGENVEC INC·Filed 1996·Granted Mar 24, 1998·123 cites·23 claims
- 0794US5712136AAdenoviral-mediated cell targeting commanded by the adenovirus penton base proteinGENVEC INC·Filed 1996·Granted Jan 27, 1998·140 cites·52 claims
- 0892US6472176B2Polynucleotide encoding chimeric protein and related vector, cell, and method of expression thereofGENVEC INC·Filed 2000·Granted Oct 29, 2002·31 cites·25 claims
- 0988US8920813B2Adenoviral vector-based dengue fever vaccineBRUDER JOSEPH T·Filed 2011·Granted Dec 30, 2014·8 cites·20 claims
- 1088US6455314B1Alternatively targeted adenovirusGENVEC INC·Filed 1999·Granted Sep 24, 2002·82 cites·60 claims
- 1187US8765146B2Adenoviral vector-based malaria vaccinesBRUDER JOSEPH T·Filed 2006·Granted Jul 1, 2014·8 cites·8 claims
- 1284US6756044B1Antigenic complexes and methodsGENVEC INC·Filed 2000·Granted Jun 29, 2004·11 cites·43 claims
- 1381US9833502B2Malaria antigens and methods of useGENVEC INC·Filed 2013·Granted Dec 5, 2017·1 cites·23 claims
- 1480US8323663B2Adenoviral vector-based foot-and-mouth disease vaccineBROUGH DOUGLAS E·Filed 2008·Granted Dec 4, 2012·7 cites·9 claims
- 1578US6576456B2Chimeric adenovirus fiber proteinCORNELL RES FOUNDATION INC·Filed 1999·Granted Jun 10, 2003·31 cites·21 claims
- 1670US10022432B2Malaria antigens and methods of useGENVEC INC·Filed 2017·Granted Jul 17, 2018·0 cites·35 claims
- 1768US6998263B2Methods of preparing and using a viral vector libraryGENVEC INC·Filed 2001·Granted Feb 14, 2006·3 cites·6 claims
- 1867US10780153B2Malaria antigens and methods of useGENVEC INC·Filed 2019·Granted Sep 22, 2020·0 cites·19 claims
- 1966US6596270B2Methods of administering adenoviral vectorsGENVEC INC·Filed 2001·Granted Jul 22, 2003·2 cites·12 claims
- 2063US10314901B2Malaria antigens and methods of useGENVEC INC·Filed 2018·Granted Jun 11, 2019·0 cites·20 claims
- 2161US6440944B2Methods of administering adenoviral vectorsGENVEC INC·Filed 1998·Granted Aug 27, 2002·19 cites·15 claims
- 2260US2025213727A1Dominant-negative tumor necrosis factor alpha adeno-associated virus gene therapyREGENXBIO INC·Filed 2023·Application pending·0 cites
- 2360US2025288697A1Vectorized anti-tnf-alpha inhibitors for ocular indicationsREGENXBIO INC·Filed 2023·Application pending·0 cites
- 2459US8450055B2Malaria antigen screening methodBRUDER JOSEPH T·Filed 2006·Granted May 28, 2013·0 cites·13 claims
- 2559US2003166286A1Chimeric adenoviral fiber protein and methods of using sameCORNELL RES FOUNDATION INC·Filed 2002·Application pending·0 cites
- 2658US6391612B1Vectors, cells, and methods for the production of deleterious adenoviral, herpes viral and adeno-associated viral vectorsGENVEC INC·Filed 1999·Granted May 21, 2002·10 cites·25 claims
- 2758US2008248060A1Adenoviral vector-based malaria vaccinesGENVEC INC·Filed 2008·Application pending·0 cites
- 2858US2002110545A1Adenovector pharmaceutical compositionGENVEC INC·Filed 2001·Application pending·0 cites
- 2957US2010278870A1Adenoviral vector-based malaria vaccinesJACKSON H M FOUND MILITARY MED·Filed 2008·Application pending·0 cites
- 3057US2002004040A1Complementary adenoviral vector systems and cell linesGENVEC INC·Filed 2001·Application pending·0 cites
- 3157US2023390418A1Vectorized factor xii antibodies and administration thereofREGENXBIO INC·Filed 2021·Application pending·0 cites
- 3256US2025001006A1Recombinant adeno-associated viruses for targeted deliveryREGENXBIO INC·Filed 2022·Application pending·0 cites
- 3356US2024384292A1Vectorized tnf-alpha antagonists for ocular indicationsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 3456US2001043922A1Complementary adenoviral vector systems and cell linesFiled 2001·Application pending·0 cites
- 3556US2024309076A1Tau-specific antibody gene therapy compositions, methods and uses thereofREGENXBIO INC·Filed 2021·Application pending·0 cites
- 3655US2025179518A1Recombinant adeno-associated viruses for cns tropic deliveryREGENXBIO INC·Filed 2022·Application pending·0 cites
- 3754US2002155602A1Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectorsGENVEC INC·Filed 2002·Application pending·0 cites
- 3853US2023381341A1Adeno-associated viruses for ocular delivery of gene therapyREGENXBIO INC·Filed 2021·Application pending·0 cites
- 3952US2017219560A1Malaria antigen screening methodUS NAVY·Filed 2017·Application pending·0 cites
- 4052US2025326861A1Vectorized lanadelumab and administration thereofREGENXBIO INC·Filed 2021·Application pending·0 cites
- 4151US2023374541A1Recombinant adeno-associated viruses for cns or muscle deliveryREGENXBIO INC·Filed 2021·Application pending·0 cites
- 4250US2024124890A1Vectorized anti-cgrp and anti-cgrpr antibodies and administration thereofREGENXBIO INC·Filed 2021·Application pending·0 cites
- 4350US2023391864A1Vectorized anti-tnf-alpha antibodies for ocular indicationsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 4446US9651543B2Malaria antigen screening methodBRUDER JOSEPH T·Filed 2013·Granted May 16, 2017·0 cites·6 claims
- 4546US2015157700A1Adenoviral vector-based malaria vaccineGANVEC INC·Filed 2013·Application pending·0 cites
- 4643US9254316B2Adenoviral vector-based malaria vaccinesBRUDER JOSEPH T·Filed 2013·Granted Feb 9, 2016·0 cites·24 claims
- 4743US2022195462A1Fully-human post-translationally modified antibody therapeuticsREGENXBIO INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Joseph T. Bruder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →